No Data
No Data
INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Competitors
INOVIO to Present at Upcoming Scientific Conferences
Inovio Pharmaceuticals Inc. Stock Rallies 10.7%, Outperforms Competitors